小谷 祐樹 | Yuki KOTANI Profile picture
集中治療医、臨床研究者。日赤和歌山▶︎亀田総合病院▶︎イタリア留学▶︎亀田総合病院。ICU分野の重要文献のエッセンスに私的感想を添えて投稿。ショック、気管挿管、AKIが好き。Intensivist & researcher. ESICM SoMe member.
Dec 26, 2023 16 tweets 9 min read
✅Summary of Key ICU RCTs in the 2nd half of 2023!

Specifically, this list covers 14 trials published in NEJM, JAMA, and Lancet between July and December of this year!

I hope this 🧵 will help you review the best RCTs of the year😉

#FOAMcc @NEJM @JAMA_current @TheLancet Image 1. Extracorporeal Life Support in Infarct-Related Cardiogenic Shock (ECLS-SHOCK): NEJM

In patients with AMI & cardiogenic shock, ECLS did not reduce 30-day mortality compared to medical therapy.

☝️ECLS increased bleeding & ischemic complications.
🔗 nejm.org/doi/full/10.10…
Image
Oct 25, 2023 5 tweets 5 min read
Report of @ESICM consensus on shock & hemodynamic monitoring @DrMCecconi

1️⃣methodology @MGrecoMD

What role does the methodological team play?
Which approach was applied?
What aspect should be considered?

#LIVES2023


Image
Image
Image
Image
Shock definition Prof. Jan Bakker

- Shock is an acute circulatory failure with reduced hypoperfusion
- Lactate is often elevated
- Hypotension is NOT a requisite

#LIVES2023 #FOAMcc
Image
Image
Jul 24, 2023 15 tweets 8 min read
✅Summary of Important RCTs in ICU for the First Half of 2023!

Quickly summarize the intensive care RCTs published from January to June this year!

Specifically, 13 trials in NEJM, JAMA, and Lancet!

I hope this 🧵 is a useful review of important literature👇👇
#FOAMcc 1. ECPR for Refractory Out-of-Hospital Cardiac Arrest: NEJM

ECPR did not increase neurologically favorable survival at 30 days when compared to conventional CPR after OHCA caused by an initial VT/VF.

☝️1st multicenter RCT on ECPR
🔗 https://t.co/8VVqpxnymcnejm.org/doi/full/10.10…
Image
Mar 23, 2023 4 tweets 4 min read
Day 3 of #ISICEM23 begins with
Sepsis: the first steps

There are many things to do in the first few hours of sepsis care, e.g.,
🦠Sampling for pathogens
💉Antibiotics
📝Severity assessment
🫀Resuscitation

This session will address a whole picture of the initial TO DOs!
@ISICEM Sepsis prediction is challenging

🔸Heterogeneity
🔸High AUROC ≠ High utility in clinical context
🔸Poor generalizability to different settings (units, department)
🔸Necessity of prediction??

@ISICEM #ISICEM23
Mar 22, 2023 8 tweets 9 min read
The #vasopressor session has started with 1️⃣“When is radial artery pressure unreliable?”

Detection
🔸Invasive vs Non-invasive
🔸Brain monitoring
🔸Mitral valve gradient
🔸Artery stenosis
🔸Waveform

👇Possible mechanisms of radial vs femoral differences
@ISICEM #isicem23 2️⃣Peripheral vasopressor use @HalliePrescott

🔸Low rates of complications reported up to 48 h with monitoring protocol

🔸Peripheral administration may avoid central line insertion (& its complications)

🔸Peripheral administration is becoming more common.

@ISICEM #isicem23
Mar 21, 2023 5 tweets 6 min read
Future sepsis therapies session💉🦠

Disease tolerance by Christopher Seymour @seymoc

🔸Difficulties in measurement
🔸May become a new focus in future clinical trials

@ISICEM #isicem23 Immune stimulation by Anthony Gordon @agordonICU

🔸Sepsis occurs as a result of dysregulated immune reactions.

🤔What happens when stimulating the immune system in patients with immune suppression?

A large RCT on GM-CSF is ongoing.

europepmc.org/grantfinder/gr…
@ISICEM #isicem23
Jan 21, 2023 4 tweets 3 min read
✅Updated norepinephrine equivalent score

How can you compare the potency of the following vasopressors?

1️⃣Norepinephrine: 0.2 μg/kg/min
2️⃣Vasopressin: 0.04 U/min
3️⃣Angiotensin II: 20 ng/kg/min

Our new publication gives you the answer👇

🔓link.springer.com/content/pdf/10…
#FOAMcc The norepinephrine equivalent (NEE) score tells you the dose of each vasopressor necessary to reach the target MAP with reference to norepinephrine.

You can find one example of NEE in the table below.
🔗journal.chestnet.org/article/S0012-…